Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature.

Grønhøj C, Jensen DH, Agander T, Kiss K, Høgdall E, Specht L, Bagger FO, Nielsen FC, von Buchwald C.

BMC Cancer. 2018 Jun 7;18(1):640. doi: 10.1186/s12885-018-4567-3.

2.

Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.

Ren S, Gaykalova D, Wang J, Guo T, Danilova L, Favorov A, Fertig E, Bishop J, Khan Z, Flam E, Wysocki PT, DeJong P, Ando M, Liu C, Sakai A, Fukusumi T, Haft S, Sadat S, Califano JA.

Int J Cancer. 2018 Nov 15;143(10):2425-2436. doi: 10.1002/ijc.31778. Epub 2018 Sep 21.

3.

The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.

Harbison RA, Kubik M, Konnick EQ, Zhang Q, Lee SG, Park H, Zhang J, Carlson CS, Chen C, Schwartz SM, Rodriguez CP, Duvvuri U, Méndez E.

JCI Insight. 2018 Jul 26;3(14). pii: 99327. doi: 10.1172/jci.insight.99327. eCollection 2018 Jul 26.

4.

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.

Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, Brown C, Pugh TJ, Stojanov P, Cho J, Lawrence MS, Getz G, Brägelmann J, DeBoer R, Weichselbaum RR, Langerman A, Portugal L, Blair E, Stenson K, Lingen MW, Cohen EE, Vokes EE, White KP, Hammerman PS.

Clin Cancer Res. 2015 Feb 1;21(3):632-41. doi: 10.1158/1078-0432.CCR-13-3310. Epub 2014 Jul 23.

5.

Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas.

Gao G, Wang J, Kasperbauer JL, Tombers NM, Teng F, Gou H, Zhao Y, Bao Z, Smith DI.

BMC Cancer. 2019 Apr 11;19(1):352. doi: 10.1186/s12885-019-5536-1.

6.

Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.

Chakravarthy A, Henderson S, Thirdborough SM, Ottensmeier CH, Su X, Lechner M, Feber A, Thomas GJ, Fenton TR.

J Clin Oncol. 2016 Dec;34(34):4132-4141. Epub 2016 Oct 31.

7.

Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.

Sewell A, Brown B, Biktasova A, Mills GB, Lu Y, Tyson DR, Issaeva N, Yarbrough WG.

Clin Cancer Res. 2014 May 1;20(9):2300-11. doi: 10.1158/1078-0432.CCR-13-2585. Epub 2014 Mar 5.

8.

Genomic characterization of clonal evolution during oropharyngeal carcinogenesis driven by human papillomavirus 16.

Chae J, Park WS, Kim MJ, Jang SS, Hong D, Ryu J, Ryu CH, Kim JH, Choi MK, Cho KH, Moon SH, Yun T, Kim JI, Jung YS.

BMB Rep. 2018 Nov;51(11):584-589.

9.

Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.

Anayannis NV, Schlecht NF, Belbin TJ.

Arch Pathol Lab Med. 2015 Nov;139(11):1373-8. doi: 10.5858/arpa.2014-0554-RA. Epub 2015 May 15. Review.

PMID:
25978766
10.

HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.

Kostareli E, Holzinger D, Bogatyrova O, Hielscher T, Wichmann G, Keck M, Lahrmann B, Grabe N, Flechtenmacher C, Schmidt CR, Seiwert T, Dyckhoff G, Dietz A, Höfler D, Pawlita M, Benner A, Bosch FX, Plinkert P, Plass C, Weichenhan D, Hess J.

J Clin Invest. 2013 Jun;123(6):2488-501. doi: 10.1172/JCI67010. Epub 2013 May 1.

11.

Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer.

Gao G, Johnson SH, Kasperbauer JL, Eckloff BW, Tombers NM, Vasmatzis G, Smith DI.

J Clin Virol. 2014 Mar;59(3):195-200. doi: 10.1016/j.jcv.2013.12.006. Epub 2013 Dec 28.

PMID:
24440282
12.

HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.

van Kempen PM, van Bockel L, Braunius WW, Moelans CB, van Olst M, de Jong R, Stegeman I, van Diest PJ, Grolman W, Willems SM.

Cancer Med. 2014 Oct;3(5):1185-96. doi: 10.1002/cam4.313. Epub 2014 Jul 26.

13.

A predictive transcriptomic signature of oropharyngeal cancer according to HPV16 status exclusively.

Mirghani H, Ugolin N, Ory C, Lefèvre M, Baulande S, Hofman P, St Guily JL, Chevillard S, Lacave R.

Oral Oncol. 2014 Nov;50(11):1025-34. doi: 10.1016/j.oraloncology.2014.07.019. Epub 2014 Aug 22.

PMID:
25156715
14.

Expression of cell cycle-related proteins in oropharyngeal squamous cell carcinoma based on human papilloma virus status.

Tsuchida K, Sugai T, Uesugi N, Ishida K, Matsuura K, Sato I, Shiga K, Sato H.

Oncol Rep. 2017 Aug;38(2):908-916. doi: 10.3892/or.2017.5720. Epub 2017 Jun 14.

PMID:
28627689
15.

Comparative molecular profiling of HPV-induced squamous cell carcinomas.

Koncar RF, Feldman R, Bahassi EM, Hashemi Sadraei N.

Cancer Med. 2017 Jul;6(7):1673-1685. doi: 10.1002/cam4.1108. Epub 2017 May 29.

16.

A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers.

Guo T, Sakai A, Afsari B, Considine M, Danilova L, Favorov AV, Yegnasubramanian S, Kelley DZ, Flam E, Ha PK, Khan Z, Wheelan SJ, Gutkind JS, Fertig EJ, Gaykalova DA, Califano J.

Cancer Res. 2017 Oct 1;77(19):5248-5258. doi: 10.1158/0008-5472.CAN-16-3106. Epub 2017 Jul 21.

17.

Deregulation of SYCP2 predicts early stage human papillomavirus-positive oropharyngeal carcinoma: A prospective whole transcriptome analysis.

Masterson L, Sorgeloos F, Winder D, Lechner M, Marker A, Malhotra S, Sudhoff H, Jani P, Goon P, Sterling J.

Cancer Sci. 2015 Nov;106(11):1568-75. doi: 10.1111/cas.12809. Epub 2015 Oct 16.

18.

Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle.

Saba NF, Wilson M, Doho G, DaSilva J, Benjamin Isett R, Newman S, Chen ZG, Magliocca K, Rossi MR.

Head Neck Pathol. 2015 Jun;9(2):223-35. doi: 10.1007/s12105-014-0566-0. Epub 2014 Sep 19.

19.

Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.

Rietbergen MM, Snijders PJ, Beekzada D, Braakhuis BJ, Brink A, Heideman DA, Hesselink AT, Witte BI, Bloemena E, Baatenburg-De Jong RJ, Leemans CR, Brakenhoff RH.

Int J Cancer. 2014 May 15;134(10):2366-72. doi: 10.1002/ijc.28580. Epub 2013 Nov 19.

20.

From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas.

Boscolo-Rizzo P, Pawlita M, Holzinger D.

Cancer Treat Rev. 2016 Jan;42:24-9. doi: 10.1016/j.ctrv.2015.10.009. Epub 2015 Oct 31. Review.

PMID:
26547133

Supplemental Content

Support Center